NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 5.3% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.25% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.47% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.03% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.88% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.81% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.31% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.29% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.24% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 2.23% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 2.08% |
| IDYA | Ideaya Biosciences Inc | Healthcare | Biotechnology | 2% |
| IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 1.98% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 1.87% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.86% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.84% |
| MRUS | Merus BV | Healthcare | Biotechnology | 1.77% |
| MLTX_old | Multex Com Inc | Other | Other | 1.73% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 1.61% |
| CLDX | Celldex Therapeutics Inc | Healthcare | Biotechnology | 1.59% |
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.